[Identification of a metabolic immune regulator in the host that protects against influenzal pneumonia]
- PMID: 34024644
- DOI: 10.1016/j.rmr.2021.05.003
[Identification of a metabolic immune regulator in the host that protects against influenzal pneumonia]
Abstract
The 'flu, caused mostly by influenza A and B viruses, represents a major public health issue. Despite vaccines and antiviral drugs, the therapeutic arsenal is still suboptimal. Recently, several studies have reported the antiviral and anti-inflammatory properties of several host metabolites. Now, we show that a metabolite (called here "C2") has a potent anti-influenza activity by blocking the viral replication and by limiting the downstream pro-inflammatory signalling. These results pave the way for the development of innovative metabolic therapy against influenzal pneumonia.
Keywords: Antiviral therapy; Immunometabolism; Immunométabolisme; Influenza; Thérapie anti-grippale; Virus.
Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous